EMEA-001129-PIP01-11-M02

Key facts

Invented name
Plegridy
Active substance
Pegylated human interferon beta-1a
Therapeutic area
Neurology
Decision number
P/0127/2018
PIP number
EMEA-001129-PIP01-11-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Biogen Idec Ltd
Tel. +44 (0)1628 501014
E-mail: pip.enquiries@biogen.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating